Potentials for the use of 755-nm laser irradiation in acne treatment with systemic isotretinoin
Filatova K.M., Nemchaninova O.B., Reshetnikova T.B.
This study is aimed to discussion of the feasibility of safely performing laser cosmetic procedures in patients with acne who are currently taking or have recently completed treatment with systemic isotretinoin (SI). This article analyzes literature data on practical experience with laser hair removal and laser correction of post-inflammatory hyperpigmentation. Special attention is given to a review of scientific research and experience with the use of the alexandrite laser, which generates 755-nm light, in dermatology and cosmetology. The current literature available for review does not contain convincing data supporting restrictions on laser procedures for at least 6 months after discontinuing oral isotretinoin therapy for acne. Furthermore, publications devoted to the combination of this drug and 755 nm laser radiation are extremely limited, confirming the relevance of further research in this area.
For citations: Filatova K.M., Nemchaninova O.B., Reshetnikova T.B. Potentials for the use of 755-nm laser irradiation in acne treatment with systemic isotretinoin. Pharmateca. 2026;33(5):13-17. (In Russ.). DOI: https://dx.doi.org/10.18565/pharmateca.2026.5.13-17
Authors’ contribution: Filatova K.M. – data collection and processing, writing. Nemchaninova O.B. – study concept and design, data analysis. Reshetnikova T.B. – data analysis, editing.
Conflicts of interest: The authors confirm that they have no conflicts of interest to declare.
Funding: The study was conducted without any sponsorship.
Keywords
acne
systemic isotretinoin
alexandrite laser
laser hair removal
laser treatment
post-inflammatory hyperpigmentation
About the Authors
Ksenia M. Filatova, Postgraduate Student, Department of Dermatovenereology and Cosmetology, Novosibirsk State Medical University, Novosibirsk; Clinic Physician, Novolaser Clinic Network, Novosibirsk, Russia; kskorolyova@mail.ru, ORCID: https://orcid.org/0009-0009-0712-6582 (corresponding author)Olga B. Nemchaninova, Dr. Sci. (Med.), Professor, Head of the Department of Dermatovenereology and Cosmetology, Novosibirsk State Medical University, Novosibirsk, Russia; obnemchaninova@mail.ru, ORCID: https://orcid.org/0000-0002-5961-6980, eLibrary SPIN: 5658-9359
Tatyana B. Reshetnikova, Dr. Sci. (Med.), Professor, Department of Dermatovenereology and Cosmetology, Novosibirsk State Medical University, Novosibirsk, Russia; tatyanaresh@mail.ru, ORCID: https://orcid.org/0000-0002-6156-0875
Similar Articles
